Immunosuppressive Therapies

Heart transplantation is considered standard therapy for patients with end-stage HF, and survival and the availability of donor hearts have continued to improve over time.

Demand for transplantation has rapidly increased around the world during the past decade due to an increase in incidence of comorbidities leading to organ failure along with a rise in longevity in patient years.

As many as 27.9% of immunomodulatory or immunosuppressive regimens were changed around the time of COVID-19 vaccination, with patients responsible for most modifications, according to data published in The Lancet Rheumatology.

A 19-year-old man presented to the New England Eye Center’s retina service with new distortion and a scotoma in the left eye.